



IN VITRO ANTIBACTERIAL ACTIVITY OF KAEMPFERIA PANDURATA ROXB. AND CURCUMA 
XANTHORRHIZA ROXB. EXTRACTS IN COMBINATION WITH CERTAIN ANTIBIOTICS AGAINST 
MSSA AND MRSA 
Original Article 
 
ELIN YULINAH SUKANDAR1, NENG FISHERI KURNIATI1, KUSNANDAR ANGGADIREDJA1, ANNISA KAMIL1 
1
 Received: 09 Sep 2015 Revised and Accepted: 18 Nov 2015 
School of Pharmacy, Pharmacology and Clinical Pharmacy Research Group, Bandung Institute of Technology, Ganesha 10, Bandung, Indonesia 
Email: elin@fa.itb.ac.id  
ABSTRACT 
Objective: The aim of this study was to find an alternative treatment of MRSA infection. We evaluated the interaction of in vitro antibacterial 
activity of Kaempferia pandurata Roxb. (rhizome) or Curcuma xanthorrhiza Roxb. (rhizome) ethanolic extracts combined with commonly used 
antibiotics, namely penicillin V, ampicillin, ciprofloxacin HCl, and tetracycline HCl.  
Methods: Interaction between the plant extracts and antibiotics against Methicillin-sensitive Staphylococcus aureus (MSSA) and Methicillin-resistant 
Staphylococcus aureus (MRSA) were tested by checkerboard method and interpreted as Fractional Inhibitory Concentration (FIC) index.  
Results: Kaempferia pandurata showed a synergistic effect on all antibiotics tested against MSSA. Against MRSA, however, only combinations of 
Kaempferia pandurata and penicillin V or ampicillin which showed synergism, while others were antagonisms. Meanwhile, with Curcuma 
xanthorrhiza, only its combination with ampicillin which resulted in synergistic effect against both MSSA and MRSA, others resulted in various 
interaction responses against MSSA and MRSA. 
Conclusion: Interaction between Kaempferia pandurata and penicillin V or ampicillin and that between Curcuma xanthorrhiza and ampicillin 
resulted in synergistic effect against MRSA. These combinations are promising to be developed as an alternative strategy to treat MRSA.  
Keywords: Antibacterial activity, Plants extract–drug interaction, MSSA, MRSA. 
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INTRODUCTION 
Methicillin-sensitive Staphylococcus aureus (MSSA) has developed to 
become resistant bacteria, known as Methicillin-resistant 
Staphylococcus aureus (MRSA) [1]. The current treatments for MSSA 
are limited. MRSA has been reported to be resistant to beta-lactams, 
aminoglycosides, fluoroquinolones and macrolides [2]. Therefore, 
the need in finding a new drug to treat bacterial infection is 
increased due to the occurrence of resistant bacteria. Finding a new 
compound derived from the plant as an antibacterial drug might be 
one alternative. An earlier study has reported that by combining the 
plant-derived drug with certain antibiotics reduced the minimum 
inhibitory concentrations of the antibiotics [3]. Such combination 
strategy could be a new approach to treating bacterial infection and 
reduce the occurrence of bacterial resistance. 
Among medicinal plants well-known to have potent antibacterial 
activities are Kaempferia pandurata Roxb. and Curcuma xanthorrhiza 
Roxb. These plants are, therefore, expected to have beneficial effects 
when combined with antibiotics. Kaempferia pandurata Roxb or 
fingerroot, belonging to the family Zingiberaceae, is a ginger species 
that is widely found in Southeast Asia, Sri Lanka, India, and Southern 
China. The fresh rhizomes are used to treat illnesses such as swelling, 
wounds, dental caries, dermatitis, dry cough and cold, tooth and gum 
disease, diarrhea, dysentery, and as diuretic. Fingerroot rhizomes 
contain many compounds, ranging from the chalcone derivatives, 
flavonoid derivatives, kawains, terpenes, esters, and terpenoids. These 
compounds have been shown to exhibit high medicinal potential. 
Previous studies have reported that K. pandurata showed 
antimicrobial, antiparasitic, antioxidant, antiulcer, antiobesity, 
antimutagenic, antitumor, antifungal, anti-inflammatory, antiviral, and 
wound healing activities [4]. Furthermore, an early work reported that 
the ethanol extract of fingerroot rhizome had antibacterial activity 
against MSSA, MRSA, Methicillin-resistant coagulase-negative 
Staphylococci (MRCNS), Bacillus subtilis, and Salmonella typhi, with 
MIC of 2-16 μg/ml [5]. Panduratin A, a natural chalcone compound 
isolated from the fingerroot rhizomes was also found to possess strong 
in vitro antimicrobial activity against clinical Staphylococcus and 
Enterococci strains [6, 7]. 
Curcuma xanthorrhiza Roxb., commonly known as temulawak or 
Javanese turmeric is one type of herbs derived from family 
Zingiberaceae. It is used in Southeast Asian countries for food and 
medicinal purposes. C. xanthorrhiza has been traditionally used to 
treat stomach disease, liver disorder, constipation, dysentery, 
diarrhea, children’s fever, and hemorrhoids [8]. The rhizomes contain 
two classes of characteristic constituents. The main substances are 
curcuminoids (1-2%) such as curcumin, desmethoxycurcumin, and 
bisdemethoxycurcumin, and volatile oil (3-12%) composed mainly of 
sesquiterpenes, xanthorrhizol, and a small amount of camphor. 
Curcumin and xanthorrhizol are the principal components of C. 
xanthorrhiza that have a wide range of pharmacological activities 
including hepatoprotective, antioxidant, antiinflammatory, 
immunomodulatory, antimutagenic, anticarcinogenic, hypolipidaemic, 
antimicrobial, antifungal, insecticidal, anti aging, and anticoagulation 
[9]. An ethanol extract of C. xanthorrhiza has been demonstrated to 
inhibit the growth of Staphylococcus aureus, Streptococcus mutans, and 
Bacillus cereus with a MIC of 0.1-2.0% (w/v) [10]. Xanthorrhizol, a 
natural sesquiterpenoid compound isolated from the turmeric 
rhizomes have been known to have powerful antibacterial activity 
against S. mutans and oral pathogens [8, 11].  
In the present study, we evaluated the interaction of in vitro 
antibacterial activity of Kaempferia pandurata Roxb. (rhizome) or 
Curcuma xanthorrhiza Roxb. (rhizome) ethanolic extracts combined 
with commonly used antibiotics, namely penicillin V, ampicillin, 
ciprofloxacin HCl, and tetracycline HCl, in an attempt to find an 
alternative treatment of MRSA infection.  
MATERIALS AND METHODS 
Chemicals 
Mueller Hinton Agar (MHA) and Mueller-Hinton Broth (MHB) (Oxoid 
Ltd., Hampshire, England) were used as growth media for bacteria. 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 8, Issue 1, 2016 
Sukandar et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 1, 108-111 
 
109 
96% ethanol and dimethylsulfoxide (DMSO, Merck, Germany) were 
obtained from School of Pharmacy, Bandung Institute of Technology. 
Penicillin V, ampicillin, ciprofloxacin HCl, and tetracycline HCl were 
obtained from Brataco Chemical, Indonesia. 
Plant collection and identification 
Fresh rhizomes of Kaempferia pandurata were collected from the 
garden in Tanjungkerta village, Sumedang, Indonesia. Curcuma 
xanthorrhiza rhizome was freshly harvested and collected in the 
garden of Cipendey village, Majalengka, Indonesia. Identification of 
plants was performed in Herbarium Bandungense, School of Life 
Sciences and Technology, Bandung Institute of Technology. 
Rhizomes and leaves were sorted, washed, chopped, and dried using 
the oven (WTB binder) at 
In vitro susceptibility test was performed in a 96-well microtiter 
plate to determine minimum inhibitory concentrations (MICs) of 
plant extracts and antibiotics against tested bacterial strains using 
standard Broth microdilution methods with an inoculum of 5 x 10
40-45 °C for several days. The dried 
rhizomes then were grounded to a fine powder.  
Microorganism tested and culture 
Methicillin-sensitive Staphylococcus aureus (MSSA) was obtained 
from the culture collection of School of Pharmacy, Bandung Institute 
of Technology. Methicillin-resistant Staphylococcus aureus (MRSA) 
was obtained from clinical patient isolate at Hasan Sadikin Hospital, 
Bandung. All of bacteria strains were cultured aerobically in MHA 
and MHB medium. 
Extraction 
The rhizome of Kaempferia pandurata and Curcuma xanthorrhiza 
were extracted by reflux using 96% ethanol as solvent. The ethanol 
extracts were filtered through filter paper (Whatman No. 1) and 
concentrated by a rotary evaporator (Buchi R-125) to obtain viscous 
extracts. The viscous extracts were stored at room temperature and 
protected from sunlight.  
Determination the susceptibility of bacteria 
5 
CFU/ml, according to the guidelines of CLSI standard M7-A8 [12]. 
Briefly, the extracts and antibiotics were first diluted in 20% DMSO, 
followed by two-fold dilutions in the test well and tested over a 
range of concentrations from 0.5 to 4096 μg/ml against overnight 
broth cultures of MSSA and MRSA. There was positive control (only 
medium and inoculum) and negative control (only medium) for all 
samples in each plate. Microtiter plates were incubated aerobically 
at 37 °C for 24 h. The MIC was defined as the lowest concentration of 
antimicrobial agent that resulted in the complete inhibition of visible 
growth. Minimum bactericidal concentrations (MBCs) were 
established for each test sample. Briefly, medium (approximately 
100 μl) from each well showing no visible growth was spread onto 
MHA plates. Plates were incubated at 37 °C for 24 h or until growth 
was seen in the growth-positive control plates. MBC was defined as 
the lowest concentration of antimicrobial agent at which all bacteria 
in the culture are killed or the lowest concentration of drug that kills 
99.9% of the total initially viable cells [13]. Experiments were 
conducted in triplicate. 
The effects of interactions between plant extracts and antibiotics 
against bacterial strains were evaluated using the modification and 
simplified checkerboard technique. The test for the antimicrobial 
combination was performed using a 96-well microtiter plate, round 
bottom microdilution plate with MHB. Antimicrobial activity of each 
plant extract in combination with antibiotic were tested (in 
quadruplicate) against each microorganism. The highest 
concentration of extract A and antibiotic B used in combination was 
2 times of each MIC. Furthermore, dilutions of plant extract and 
antibiotic were made with a series of twofold dilution. The extract A 
and antibiotic B were diluted twofold along the x-axis and y-axis of 
the plate, respectively. Overnight broth cultures of each strain 
(MSSA and MRSA) were adjusted to10
Antimicrobial combination testing of plant extracts and 
antibiotics  
6 CFU/ml and subsequently 
were added to the wells. Negative control (only MHB) and growth 
control (MHB and inoculum) were also included in each plate. The 
plates were then incubated at 37 
The strongest antibacterial activity against MSSA for plant extract 
was shown by ethanolic extract of Kaempferia pandurata (MIC = 128 
µg/ml), while, for antibiotics, ciprofloxacin HCl showed the strongest 
activity (MIC = 0.5 µg/ml). Furthermore, the MIC for all tested plant 
extracts and antibiotics against MRSA had higher MIC level 
compared to MSSA, suggesting that the antimicrobial activity of the 
plant extracts and antibiotics were lower against MRSA than MSSA. 
°C for 24 h and monitored for 
growth. At the end of incubation period, the MICs of each extract and 
antibiotic alone and in the combination were recorded. The MIC was 
defined as the lowest concentration of the plant extract or antibiotic 
at which visible growth is inhibited. To evaluate the effect of 
combinations, the fractional inhibitory concentration index (FIC 
index) was calculated for each of the combinations according to the 
formula below. 








The results were interpreted as synergism (FIC index ≤ 0.5), additive 
(FIC index 1), and antagonism (FIC index>2) [14]. 
RESULTS AND DISCUSSION 
Antimicrobial activity of plant extracts and antibiotics alone 
against MSSA and MRSA 
In vitro antibacterial activity of plant extract and antibiotics was 
quantitatively investigated in terms of minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC) 
and results are represented in table 1. The MIC of plant extracts and 
antibiotic was varied, depending on the type of plant extract and 
antibiotic and the strain of bacteria tested. In general, all the plant 
extracts and antibiotics exerted antibacterial effects.  
 
Table 1: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of plant extracts and antibiotics 
against MSSA and MRSA 
Plant extract and antibiotic MSSA MRSA 
MIC (µg/ml) MBC (µg/ml) MIC (µg/ml) MBC (µg/ml) 
Kaempferia pandurata extract 128 256 2048 4096 
Curcuma xanthorrhiza extract 256 512 2048 4096 
Penicillin V 8 16 64 64 
Ampicillin 2 4 8 8 
Ciprofloxacin HCl 0.5 0.5 64 64 
Tetracycline HCl 8 16 32 64 
 
Note: Experiments were conducted in triplicate. 
Minimum bactericidal concentrations (MBCs) were also 
determined for each plant extracts and antibiotics. The results 
showed that in general, the MBC values were equal to (MBC = MIC) 
or two times greater than the MIC (MBC= 2 x MIC). The MIC and 
MBC values of the ethanolic plant extracts were higher than the 
antibiotics.  
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Effects of combination between plant extracts and antibiotics in 
antimicrobial activity 
The antibacterial activity of the combination of each plant extract and 
antibiotics against MSSA and MRSA are shown in table 2 and table 3.  
Against MSSA, the interaction between Kaempferia pandurata with 
each antibiotic tested showed a synergistic effect. The MIC value of 
Kaempferia pandurata and antibiotic in combination was reduced up 
to 1/4-1/8 MIC. Moreover, for Curcuma xanthorrhiza, only 
interaction with ciprofloxacin HCl and tetracycline HCl that showed 
a synergistic effect. While the interaction between Curcuma 
xanthorrhiza and penicillin V or tetracycline HCl showed additive 
and antagonistic effect, respectively. Against MRSA, a combination of 
Kaempferia pandurata or Curcuma xanthorrhiza with penicillin V or 
ampicillin gave a synergistic effect. An additive effect was found 
when Curcuma xanthorrhiza was combined with tetracycline HCl.  
Moreover, the antagonistic effect was observed when ciprofloxacin 
HCl was combined with ethanolic extracts of Kaempferia pandurata 
or Curcuma xanthorrhiza, and when tetracycline HCl was combined 
with extracts of Kaempferia pandurata. According to FIC index, 
MRSA exerted the greatest resistance to most of the combinations 
between plant extract and antibiotic. 
  
Table 2: Fractional inhibitory concentration (FIC) index of combinations of plant extract and antibiotic against MSSA 
Combinations MIC FIC index Interactions 
Plant extracts Antibiotics 
Kaempferia pandurata  Penicillin V 1/8+1/8 0.25 Synergism 
Ampicillin 1/8+1/8 0.25 Synergism 
Ciprofloxacin HCl 1/8+1/8 0.25 Synergism 
Tetracycline HCl 1/4+1/4 0.50 Synergism 
Curcuma xanthorrhiza  Penicillin V 1/2+1/2 1.00 Additive 
Ampicillin 1/8+1/8 0.25 Synergism 
Ciprofloxacin HCl 1/8+1/8 0.25 Synergism 
Tetracycline HCl 1+1 2.00 Antagonism 
Note: Experiments were conducted in 
 
quadruplicate.  
Table 3: Fractional inhibitory concentration (FIC) index of combinations of plant extract and antibiotic against MRSA 
Combinations MIC FIC index Interactions 
Plant extracts Antibiotics 
Kaempferia pandurata  Penicillin V 1/8+1/8 0.25 Synergism 
Ampicillin 1/8+1/8 0.25 Synergism 
Ciprofloxacin HCl 1+1 2.00 Antagonism 
Tetracycline HCl 2+2 4.00 Antagonism 
Curcuma xanthorrhiza  Penicillin V 1/8+1/8 0.25 Synergism 
Ampicillin 1/8+1/8 0.25 Synergism 
Ciprofloxacin HCl 2+2 4.00 Antagonism 
Tetracycline HCl 1/2+1/2 1.00 Additive 
Note: Experiments were conducted in quadruplicate
 
. 
In this study, the synergistic effects resulted from the combination of 
antibiotics with plant extracts varied against different bacteria. 
These results were in agreement with a previous report [15]. In that 
report, it demonstrated the synergistic property of combination of 
doxycycline with ethanolic leaf extract of Vangueria spinosa against 
Staphylococcus aureus, Escherichia coli, and Klebsiella pneumonia 
[15]. Such combination, however, showed additive interaction 
against Pseudomonas aeruginosa [15].  
This synergistic action can occur due to the favorable interactions 
between the active component of plant extracts and antibiotics. The 
synergistic effect that was detected in this study suggests that plant 
extract is a mixture of compounds [16] that can enhance the activity 
of different antibiotics. One of the mechanisms of action of the 
synergistic interaction that has been reported was increasing the 
permeability of the cell membrane which leads to the increased 
penetrability of antibiotics [16]. These results revealed that the 
combined use of plant extracts and antibiotics could be useful in the 
treatment of infectious bacterial disease and useful in overcoming 
drug resistance problem although clinical controlled studies are 
needed to confirm the real efficacy and possible toxic effects in vivo. 
Therefore, understanding the mechanism of action of combination of 
antibiotics with plant extracts against bacteria is fundamental to the 
development of pharmacological agents to treat bacterial infections 
using the medicinal plant. 
CONCLUSION 
In conclusion, the results presented in this study showed that there 
were synergistic antibacterial effects between ethanolic plant 
extracts and antibiotics against MSSA and MRSA bacteria. The 
interaction between Kaempferia pandurata and penicillin V or 
ampicillin and interaction between Curcuma xanthorrhiza and 
ampicillin was shown to be synergistic against MRSA. These 
combinations can be used as an alternative strategy to treat MRSA.  
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